It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Canonical RNA processing in mammalian mitochondria is defined by tRNAs acting as recognition sites for nucleases to release flanking transcripts. The relevant factors, their structures, and mechanism are well described, but not all mitochondrial transcripts are punctuated by tRNAs, and their mode of processing has remained unsolved. Using Drosophila and mouse models, we demonstrate that non-canonical processing results in the formation of 3′ phosphates, and that phosphatase activity by the carbon catabolite repressor 4 domain-containing family member ANGEL2 is required for their hydrolysis. Furthermore, our data suggest that members of the FAST kinase domain-containing protein family are responsible for these 3′ phosphates. Our results therefore propose a mechanism for non-canonical RNA processing in metazoan mitochondria, by identifying the role of ANGEL2.
A subset of mitochondrial transcripts is not flanked by tRNAs and thus does not conform to the canonical mode of processing. Here, Clemente et al. demonstrate that phosphatase activity of ANGEL2 is required for correct processing of these transcripts.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
2 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Edinburgh, Simons Initiative for the Developing Brain, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
3 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Max Planck Institute of Biochemistry, Planegg/Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X)
4 Thomas Jefferson University, Computational Medicine Center, Sidney Kimmel Medical College, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843)
5 QEII Medical Centre and University of Western Australia, Harry Perkins Institute of Medical Research, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); QEII Medical Centre and University of Western Australia, ARC Centre of Excellence in Synthetic Biology, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910)
6 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Karolinska University Hospital, Centre for Inherited Metabolic Diseases, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705)
7 QEII Medical Centre and University of Western Australia, Harry Perkins Institute of Medical Research, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); QEII Medical Centre and University of Western Australia, ARC Centre of Excellence in Synthetic Biology, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); Curtin University, Curtin Medical School and Curtin Health Innovation Research Institute, Bentley, Australia (GRID:grid.1032.0) (ISNI:0000 0004 0375 4078); Telethon Kids Institute, Northern Entrance, Perth Children’s Hospital, Nedlands, Australia (GRID:grid.1032.0)
8 QEII Medical Centre and University of Western Australia, Harry Perkins Institute of Medical Research, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); QEII Medical Centre and University of Western Australia, ARC Centre of Excellence in Synthetic Biology, Nedlands, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); Curtin University, Curtin Medical School and Curtin Health Innovation Research Institute, Bentley, Australia (GRID:grid.1032.0) (ISNI:0000 0004 0375 4078)
9 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Max Planck Institute Biology of Ageing—Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)